NephroNet is a network of dedicated clinicians, investigators and affiliated sponsors that are collectively committed to advancing patient education, research and the realization of new methods to treat kidney disease. Our non-profit organization provides education for patients on the nature of their disease, treatment options as well as long-term options including the need for dialysis or transplantation.
A principal goal of NephroNet is to educate patients and enable them to work with their physicians to prevent disease progression. We further these efforts by partnering with academic and industry leaders to bring new therapies and devices that will ultimately improve patient’s lives.
Meet Our Board of Directors
Universities, he is continuing in his goal to bring cutting edge and novel treatments to the CKD and ESRD patient communities.
1993. Dr. Hennigar is widely published in renal pathology; including having authored more than 50 peer-reviewed journal publications and textbook chapters. He was board certified by the American Board of Pathology in 1995. He is a member of both the College of American Pathologists and The Renal Pathology Society.
medicine at the Duke University Medical Center, Arthur continued training at Duke, completing clinical and research residencies in internal medicine, and clinical and research fellowships in nephrology. He is a member of the National Institute of Diabetes and Digestive and Kidney Diseases’ Kidney, Urologic and Hematologic Diseases D Subcommittee. Arthur serves as a grant reviewer for the American Society of
Nephrology and the American Heart Association. He is the principal investigator on a National Institutes of Health R01 grant, which is exploring biomarkers of early renal functional decline in patients with type 2 diabetes.